FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022626084> ?p ?o ?g. }

• W2022626084 endingPage "370" @default.
• W2022626084 startingPage "370" @default.
• W2022626084 abstract "ALTHOUGH SEROTONIN-REUPTAKE INHIBITOR (SRI) augmentation with antipsychotics for the treatment of body dysmorphic disorder (BDD) has recently received attention, the benefits of such augmentation remain unclear. Here, we report a case that exhibited a dramatic improvement in BDD symptoms following the addition of olanzapine to SRI therapy. The patient was a 26-year-old woman with a 10-year history of BDD. At the age of 16, she became obsessed with the idea that she must always keep her body's skin clean. She became preoccupied with the appearance of her skin and spent many hours a day grooming her body hair. At the age of 20, she experienced a relationship breakup. Thereafter, she became preoccupied with the shape of nose, believing it to be ugly. She frequently checked her nose in the mirror and asked her family for reassurance regarding her nose. Her preoccupation with her appearance resulted in her work being impaired. At the age of 24, she was first admitted to our hospital because of severe weight loss and insomnia because she wasted almost her entire day looking in mirrors and grooming her body hair. Based on the DSM-IV criteria, she was diagnosed as having BDD. In the past, she had been treated with selective serotonin reuptake inhibitors (SSRIs) and an atypical antipsychotic. Neither fluvoxamine (300 mg/day) nor risperidone augmentation of the fluvoxamine treatment diminished her BDD symptoms. Her symptoms also did not improve following the administration of paroxetine (40 mg/day). Her symptoms did not change. Therefore, at the age of 26 years, the paroxetine (40 mg/day) treatment that she was receiving was augmented with 2.5 mg/day of olanzapine. This dose was increased to 5 mg/day after a partial response was observed at 4 weeks. At 6 weeks, her preoccupation with her physical appearance began to subside. Both the amount of time and the frequency with which she checked mirrors and groomed her body hair and toes improved dramatically. This was the first remission of her symptoms since onset at the age of 20 years. Her Yale Brown Obsessive-Compulsive Scale score decreased from 39 to 20. Although she complained of undesired weight gain, at a 1-year follow-up examination, her symptoms were still in remission. Studies that previously examined the effect of the augmentation of SRI therapy with antipsychotics in patients with BDD failed to show any improvement in symptoms.1,2 To the best of our knowledge, this is the first BDD case to be successfully treated with olanzapine augmentation of paroxetine therapy. With regard to OCD patients, several studies have reported that olanzapine augmentation of ongoing SRI treatment resulted in an improvement of OCD symptoms.3,4 The present case report may support the speculation that BDD has features in common with OCD disorders. Although the neurochemical mechanism underlying BDD is unclear, the serotonin and dopamine system may interact in the mediation of BDD symptoms. Further larger placebo-controlled, double-blinded studies are required to ascertain the effect of olanzapine augmentation of SRI therapy." @default.
• W2022626084 created "2016-06-24" @default.
• W2022626084 creator A5016755613 @default.
• W2022626084 creator A5053460569 @default.
• W2022626084 creator A5085050194 @default.
• W2022626084 date "2008-06-01" @default.
• W2022626084 modified "2023-10-16" @default.
• W2022626084 title "Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder" @default.
• W2022626084 cites W1964945065 @default.
• W2022626084 cites W2016185178 @default.
• W2022626084 cites W2079314303 @default.
• W2022626084 cites W2086028965 @default.
• W2022626084 doi "https://doi.org/10.1111/j.1440-1819.2008.01813.x" @default.
• W2022626084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18588607" @default.
• W2022626084 hasPublicationYear "2008" @default.
• W2022626084 type Work @default.
• W2022626084 sameAs 2022626084 @default.
• W2022626084 citedByCount "19" @default.
• W2022626084 countsByYear W20226260842012 @default.
• W2022626084 countsByYear W20226260842014 @default.
• W2022626084 countsByYear W20226260842016 @default.
• W2022626084 countsByYear W20226260842017 @default.
• W2022626084 countsByYear W20226260842018 @default.
• W2022626084 countsByYear W20226260842019 @default.
• W2022626084 countsByYear W20226260842020 @default.
• W2022626084 countsByYear W20226260842021 @default.
• W2022626084 countsByYear W20226260842022 @default.
• W2022626084 crossrefType "journal-article" @default.
• W2022626084 hasAuthorship W2022626084A5016755613 @default.
• W2022626084 hasAuthorship W2022626084A5053460569 @default.
• W2022626084 hasAuthorship W2022626084A5085050194 @default.
• W2022626084 hasBestOaLocation W20226260841 @default.
• W2022626084 hasConcept C118552586 @default.
• W2022626084 hasConcept C126322002 @default.
• W2022626084 hasConcept C141071460 @default.
• W2022626084 hasConcept C15744967 @default.
• W2022626084 hasConcept C170493617 @default.
• W2022626084 hasConcept C187212893 @default.
• W2022626084 hasConcept C2775864247 @default.
• W2022626084 hasConcept C2776134451 @default.
• W2022626084 hasConcept C2776412080 @default.
• W2022626084 hasConcept C2776619155 @default.
• W2022626084 hasConcept C2777828372 @default.
• W2022626084 hasConcept C2778311950 @default.
• W2022626084 hasConcept C2778455770 @default.
• W2022626084 hasConcept C2779177272 @default.
• W2022626084 hasConcept C2779305415 @default.
• W2022626084 hasConcept C2779910183 @default.
• W2022626084 hasConcept C2780057945 @default.
• W2022626084 hasConcept C2780092697 @default.
• W2022626084 hasConcept C558461103 @default.
• W2022626084 hasConcept C71924100 @default.
• W2022626084 hasConceptScore W2022626084C118552586 @default.
• W2022626084 hasConceptScore W2022626084C126322002 @default.
• W2022626084 hasConceptScore W2022626084C141071460 @default.
• W2022626084 hasConceptScore W2022626084C15744967 @default.
• W2022626084 hasConceptScore W2022626084C170493617 @default.
• W2022626084 hasConceptScore W2022626084C187212893 @default.
• W2022626084 hasConceptScore W2022626084C2775864247 @default.
• W2022626084 hasConceptScore W2022626084C2776134451 @default.
• W2022626084 hasConceptScore W2022626084C2776412080 @default.
• W2022626084 hasConceptScore W2022626084C2776619155 @default.
• W2022626084 hasConceptScore W2022626084C2777828372 @default.
• W2022626084 hasConceptScore W2022626084C2778311950 @default.
• W2022626084 hasConceptScore W2022626084C2778455770 @default.
• W2022626084 hasConceptScore W2022626084C2779177272 @default.
• W2022626084 hasConceptScore W2022626084C2779305415 @default.
• W2022626084 hasConceptScore W2022626084C2779910183 @default.
• W2022626084 hasConceptScore W2022626084C2780057945 @default.
• W2022626084 hasConceptScore W2022626084C2780092697 @default.
• W2022626084 hasConceptScore W2022626084C558461103 @default.
• W2022626084 hasConceptScore W2022626084C71924100 @default.
• W2022626084 hasIssue "3" @default.
• W2022626084 hasLocation W20226260841 @default.
• W2022626084 hasLocation W20226260842 @default.
• W2022626084 hasOpenAccess W2022626084 @default.
• W2022626084 hasPrimaryLocation W20226260841 @default.
• W2022626084 hasRelatedWork W1993822978 @default.
• W2022626084 hasRelatedWork W2035167426 @default.
• W2022626084 hasRelatedWork W2057162218 @default.
• W2022626084 hasRelatedWork W2347451993 @default.
• W2022626084 hasRelatedWork W2350221331 @default.
• W2022626084 hasRelatedWork W2351013987 @default.
• W2022626084 hasRelatedWork W2364146777 @default.
• W2022626084 hasRelatedWork W2365540688 @default.
• W2022626084 hasRelatedWork W2385902241 @default.
• W2022626084 hasRelatedWork W3191217030 @default.
• W2022626084 hasVolume "62" @default.
• W2022626084 isParatext "false" @default.
• W2022626084 isRetracted "false" @default.
• W2022626084 magId "2022626084" @default.
• W2022626084 workType "article" @default.